Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
-
호주 아들레이드, July 10, 2026 (GLOBE NEWSWIRE) -- 호주에 본사를 둔 글로벌 임상시험수탁기관(CRO)인 아반스 클리니컬(Avance Clinical)은 7월 15일부터 19일까지 대만 타이베이 난강전시센터(Taipei Nangang Exhibition Center, TaiNEX)에서 열리는 'BIO Asia–Taiwan...
-
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
-
WuXi AppTec shows how integrated CRDMO platforms help protein degrader programs reach the clinic by connecting chemistry, biology, and CMC early.
-
Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Crispr-Based Drug Development Platforms Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. ...
-
Drug developers have a new, optimized option for U.S.-based manufacturing, as AGC Biologics enters a strategic partnership with Pyramid Pharma Services.
-
WuXi AppTec details how structural complexity in protein degraders, covalent agents, and kinase programs is reshaping what integrated CRDMOs must deliver.
-
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
-
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
-
Alison Strutt appointed as Chief Financial Officer, László Tankó appointed as Consultant Chief Medical Officer, and Sam Fazeli appointed Non-Executive DirectorAppointments support MitoRx’s next phase...